Evan Y. Chuck

Multinational companies with global supply chains and data-driven operations face an increasingly complex regulatory environment worldwide, particularly in Asia. Evan (PS 1986) advises corporate leaders and boards on strategic decisions amid competing U.S. and China laws shaped by geopolitical tensions.

For more than 30 years, Evan has represented companies and private equity firms in cross-border investments across critical industries, including aerospace, semiconductors, mining, electric vehicles, life sciences, and wood products. He guides clients through high-stakes transactions and investigations while developing risk mitigation strategies, such as “de-risking” exposure to China. Evan helps companies re-shore manufacturing or diversify sourcing to the U.S. and countries like Vietnam, Malaysia, Taiwan, India, Japan, Korea, Switzerland, Brazil, Ireland, Canada, and Mexico.

He advises on compliance with emerging U.S. laws, including the CHIPS and Science Act of 2022 and the pending BIOSECURE Act, which seeks to reduce reliance on Chinese biotechnology firms in U.S. life sciences supply chains.

Evan began his career in Washington, D.C., representing U.S. companies in major unfair trade disputes, particularly before U.S. government agencies like the Department of Commerce and the Office of the United States Trade Representative. He also worked on trade issues in the U.S. Congress with the House Ways and Means and Senate Finance Committees. Notably, he helped the U.S. lumber industry challenge the bi-national dispute resolution mechanism under the U.S.- Canada Free Trade Agreement.

Before joining Brownstein Hyatt Farber Schreck, Evan chaired a global firm’s international trade group for seven years and served as managing partner of its Shanghai office for another seven years.